Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized <i>Blomia tropicalis</i> vaccine.
第一单位:
Second Degree Specialist in Allergy and Integral General Medicine, Master in Transmissible Diseases, Auxiliary Professor, "General Calixto García" University Hospital, Havana University of Medical Science. Auxiliary Researcher, National Center of Bioproducts, Bejucal, Mayabeque, Cuba.
作者:
关键词
AIT, Allergen immunotherapyALK, Denmark-based pharmaceutical companyBIOCEN, National Center of BioproductsBU, Biological UnitsBU/mL, Biological units per milliliterBlo t, Mayor allegen of Blomia tropicalisBlomia tropicalisBt, Blomia tropicalis or B. tropicalisCECMED, Center for State Control of Drugs, Equipment and Medical DevicesCh10, Allergen specific reactivity calculated relative to the Histamine HC 10?mg/mLClinical trialDp or D, pteronyssinus: Dermatophagoides pteronyssinusDs or D, siboney: Dermatophagoides siboneyHDM SCIT, Immunotherpy Subcutaneous with allergens of House Dust MiteHDM, House Dust MiteOCI, Overall clinical improvementPEF, Peak Expiratory FlowSM, Symptom and MedicationSMD, Standard Mean DifferenceStandardized allergen extractSubcutaneous immunotherapyVALERGEN-BT, Standardized allergen extract of Blomia tropicalis
DOI
10.1016/j.waojou.2020.100098
PMID
32308779
发布时间
2024-03-28
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



